ArticleBlood advances2021

Outcomes of a clinician-directed protocol for discontinuation of complement inhibition therapy in atypical hemolytic uremic syndrome.

Shruti Chaturvedi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.